The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.75
Bid: 34.50
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.449%)
Open: 34.75
High: 34.75
Low: 34.75
Prev. Close: 34.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Nominated Adviser and Joint Broker

16 Oct 2023 10:16

RNS Number : 2396Q
Creo Medical Group PLC
16 October 2023
 

 

Creo Medical Group plc

("Creo" the "Company" or the "Group")

 

Change of Nominated Adviser and Joint Broker

 

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

 

Enquiries:

 

Creo Medical Group plc

www.creomedical.com

Richard Rees (CFO)

+44 (0)1291 606 005

Cavendish Capital Markets Limited

+44 (0)20 7397 8900

Stephen Keys / Camilla Hume (NOMAD)

Michael Johnson (Sales)

Numis Securities Limited (Joint Broker)

+44 (0)20 7260 1000

Freddie Barnfield / Duncan Monteith / Euan Brown

Walbrook PR Ltd

Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com

Paul McManus / Sam Allen 

Phillip Marriage 

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

+44 (0)7867 984 082

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFFLSUMEDSEFS
Date   Source Headline
3rd Oct 201812:14 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
17th Sep 20187:04 amRNSExtension of Distribution Agreement with Pentax
13th Sep 20187:00 amRNSFirst use of Speedboat in South Africa
3rd Sep 20181:34 pmRNSHolding(s) in Company
31st Aug 201811:32 amRNSHolding(s) in Company
31st Aug 201811:30 amRNSDirector/PDMR Shareholding
21st Aug 20183:59 pmRNSIssue of Equity Update - Amendment
21st Aug 20181:48 pmRNSIssue of Equity Update
20th Aug 201810:13 amRNSDirector/PDMR Shareholding
1st Aug 20181:24 pmRNSResult of General Meeting
18th Jul 20184:44 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSConditional Placing of New Ordinary Shares
9th Jul 20187:00 amRNSAgreement with First Medical Company
4th Jul 20187:00 amRNSUK Distribution Agreement with Diagmed Healthcare
2nd Jul 20187:00 amRNSMarket Update
10th May 201811:25 amRNSExercise of Options
20th Apr 20184:38 pmRNSChange of accounting reference date
20th Mar 20187:00 amRNSInterim results for six months to 31 December 2017
28th Feb 20184:32 pmRNSChange of Registered Office
12th Feb 20187:00 amRNSExercise of Options
9th Jan 20185:43 pmRNSDirector/PDMR Shareholding
22nd Dec 201712:10 pmRNSDirector/PDMR Shareholding
22nd Dec 20179:24 amRNSDirector/PDMR Shareholding
20th Dec 20171:32 pmRNSResult of AGM
29th Nov 20177:00 amRNSSpeedboat RS2 advances beyond initial pilot centre
24th Nov 201710:49 amRNSNotice of AGM
14th Nov 20177:00 amRNSFinal Results
25th Sep 20173:07 pmRNSHolding(s) in Company
18th Sep 20179:56 amRNSHolding(s) in Company
11th Sep 20172:05 pmRNSChange of Registered Office
1st Sep 20179:42 amRNSHolding(s) in Company
21st Aug 20177:00 amRNSAnnounces US FDA Approval of Speedboat RS2
29th Jun 20177:00 amRNSCreo Medical Pre-Submission 510k Confirmation
22nd Jun 20177:00 amRNSAnnounces First Patient Treated with Speedboat
4th Apr 20175:47 pmRNSDirector/PDMR Dealing
30th Mar 20177:00 amRNSCreo Medical Interim Results
24th Mar 20177:00 amRNSCreo CE Mark for microwave for Speedboat RS2
1st Mar 20177:00 amRNSAnnounces Participation in Research Programme
2nd Feb 20177:21 amRNSDirector/PDMR Shareholding
9th Dec 20167:00 amRNSCreo First Day of Dealings on AIM
17th Jun 20107:00 amRNSCity Centre Development
16th Jun 20104:00 pmRNSScheme of arrangement re Court Hearing
16th Jun 20107:00 amRNSSuspension - China Real Estate Opportunities Plc
9th Jun 201012:00 pmRNSResult of AGM
7th Jun 20101:03 pmRNSResult of EGM & Court Meeting
21st May 20107:00 amRNSPosting of Scheme Document
4th May 20104:00 pmRNSPublication of Financial Accounts
26th Apr 20107:00 amRNSUpdate on Proposed Asian Listing
26th Mar 20104:35 pmRNSShareholder notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.